A Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma
Public ClinicalTrials.gov record NCT04814108. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Adult Women With Recurrent or Persistent Uterine Serous Carcinoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2 study to evaluate the clinical activity and safety of ZN-c3 (azenosertib) in adult women with recurrent or persistent uterine serous carcinoma (USC).
Study identification
- NCT ID
- NCT04814108
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
- Industry
- Enrollment
- 92 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 28, 2021 (Actual)
- Primary completion
- Oct 22, 2025 (Actual)
- Completion
- Oct 22, 2025 (Actual)
- Last update posted
- Mar 18, 2026
2021 – 2025
United States locations
- U.S. sites
- 41
- U.S. states
- 21
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alaska Women's Cancer Care | Anchorage | Alaska | 99508 | — |
| Honor Health | Phoenix | Arizona | 85016 | — |
| Arizona Oncology Associates Wilmot HOPE | Tucson | Arizona | 85711 | — |
| Banner University Medical Center Tucson | Tucson | Arizona | 85719 | — |
| University of California Irvine Medical Center | Orange | California | 92868 | — |
| University of California San Francisco at Mission Bay | San Francisco | California | 94158 | — |
| Mount Sinai Medical Center | Miami Beach | Florida | 33140 | — |
| Sarasota Memorial Hospital | Sarasota | Florida | 34239 | — |
| University of South Florida | Tampa | Florida | 33606 | — |
| Northside Hospital | Atlanta | Georgia | 30342 | — |
| Georgia Cancer Center at Augusta University | Augusta | Georgia | 30912 | — |
| Northwestern University | Evanston | Illinois | 60208 | — |
| Maryland Oncology Hematology | Annapolis | Maryland | 21401 | — |
| University of Maryland Medical Center | Baltimore | Maryland | 21201 | — |
| Oakland Medical Group | Detroit | Michigan | 48201 | — |
| Corewell Health | Grand Rapids | Michigan | 49503 | — |
| Revive Clinical Research | Sterling | Michigan | 48659 | — |
| HCA Midwest Health Kansas City Research | Kansas City | Missouri | 64132 | — |
| Center of Hope | Reno | Nevada | 89511 | — |
| Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08901 | — |
| Optimum Clinical Research Group- Women's Oncology | Albuquerque | New Mexico | 87109 | — |
| Westchester Medical Center | Hawthorne | New York | 10532 | — |
| University of Cincinnati | Cincinnati | Ohio | 45219 | — |
| Oncology Hematology Care | Cincinnati | Ohio | 45242 | — |
| Trihealth Cancer Institute | Cincinnati | Ohio | 45242 | — |
| Ohio State University James Cancer Hospital | Columbus | Ohio | 43210 | — |
| University of Oklahoma Peggy and Charles Stephenson Cancer Center | Oklahoma City | Oklahoma | 73104 | — |
| Willamette Valley Cancer Institute | Eugene | Oregon | 97401 | — |
| Providence Portland Medical Center | Portland | Oregon | 97213 | — |
| Northwest Cancer Specialists | Portland | Oregon | 97227 | — |
| Temple University Hospital | Philadelphia | Pennsylvania | 19140 | — |
| Ascension St. Thomas Midtown Hospital | Nashville | Tennessee | 37236 | — |
| Texas Oncology Austin | Austin | Texas | 78705 | — |
| Texas Oncology Fort Worth Cancer Center | Fort Worth | Texas | 76104 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Texas Oncology Gulf Coast | Houston | Texas | 77089 | — |
| Texas Oncology San Antonio | San Antonio | Texas | 78240 | — |
| University of Virginia Cancer Center | Charlottesville | Virginia | 22908 | — |
| VCU Health System | Richmond | Virginia | 23298 | — |
| Virginia Cancer Specialists | Warrenton | Virginia | 20186 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04814108, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 18, 2026 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04814108 live on ClinicalTrials.gov.